Cargando…

No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway

OBJECTIVES: To estimate the risk of hospitalization among reported cases of the Delta variant of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) compared with the Alpha variant in Norway, and the risk of hospitalization by vaccination status. METHODS: A cohort study was conducted on lab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veneti, Lamprini, Valcarcel Salamanca, Beatriz, Seppälä, Elina, Starrfelt, Jostein, Storm, Margrethe Larsdatter, Bragstad, Karoline, Hungnes, Olav, Bøås, Håkon, Kvåle, Reidar, Vold, Line, Nygård, Karin, Buanes, Eirik Alnes, Whittaker, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664610/ https://www.ncbi.nlm.nih.gov/pubmed/34902584 http://dx.doi.org/10.1016/j.ijid.2021.12.321

Ejemplares similares

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022)

Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
por: Veneti, Lamprini, et al.
Publicado: (2021)

Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 – April 2021
por: Whittaker, Robert, et al.
Publicado: (2021)

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
por: Seppälä, Elina, et al.
Publicado: (2021)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2023)

Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients
por: Whittaker, Robert, et al.
Publicado: (2022)

Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
por: Brandal, Lin T., et al.
Publicado: (2021)

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
por: Starrfelt, Jostein, et al.
Publicado: (2022)

Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 – January 2022
por: Langlete, Petter, et al.
Publicado: (2023)

Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020
por: Brandal, Lin T, et al.
Publicado: (2021)

Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort
por: Landaas, Elisabeth Toverud, et al.
Publicado: (2021)

Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021
por: Winje, Brita Askeland, et al.
Publicado: (2021)

Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63
por: Moen, Line Victoria, et al.
Publicado: (2022)

Poor neutralizing antibody responses against SARS‐CoV‐2 Omicron BQ.1.1 and XBB in Norway in October 2022
por: Vikse, Elisabeth Lea, et al.
Publicado: (2023)

A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022
por: Nyberg, Tommy, et al.
Publicado: (2023)

Community spread and late season increased incidence of oseltamivir‐resistant influenza A(H1N1) viruses in Norway 2016
por: Bragstad, Karoline, et al.
Publicado: (2019)

Implementation of multiplex PCR diagnostics for gastrointestinal pathogens linked to increase of notified Shiga toxin-producing Escherichia coli cases in Norway, 2007–2017
por: Jenssen, Gaute Reier, et al.
Publicado: (2019)

Abrupt termination of the 2019/20 influenza season following preventive measures against COVID-19 in Denmark, Norway and Sweden
por: Emborg, Hanne-Dorthe, et al.
Publicado: (2021)

A comparison of two registry-based systems for the surveillance of persons hospitalised with COVID-19 in Norway, February 2020 to May 2022
por: Whittaker, Robert, et al.
Publicado: (2023)

Compliance with water advisories after water outages in Norway
por: Hyllestad, Susanne, et al.
Publicado: (2019)

High vaccine effectiveness against coronavirus disease 2019 (COVID-19) and severe disease among residents and staff of long-term care facilities in Norway, November 2020–June 2021
por: Starrfelt, Jostein, et al.
Publicado: (2022)

Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort
por: Laake, Ida, et al.
Publicado: (2022)

High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014
por: Bragstad, Karoline, et al.
Publicado: (2015)

Large waterborne Campylobacter outbreak: use of multiple approaches to investigate contamination of the drinking water supply system, Norway, June 2019
por: Hyllestad, Susanne, et al.
Publicado: (2020)

How many dinosaur species were there? Fossil bias and true richness estimated using a Poisson sampling model
por: Starrfelt, Jostein, et al.
Publicado: (2016)

Human to animal transmission of influenza A(H1N1)pdm09 in a turkey breeder flock in Norway
por: Sjurseth, Siri Kulberg, et al.
Publicado: (2017)

Risk factors, immune response and whole‐genome sequencing of SARS‐CoV‐2 in a cruise ship outbreak in Norway
por: Gravningen, Kirsten, et al.
Publicado: (2022)

Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation
por: Johansen, Silje, et al.
Publicado: (2022)

Mapping of control measures to prevent secondary transmission of STEC infections in Europe during 2016 and revision of the national guidelines in Norway
por: Veneti, L., et al.
Publicado: (2019)

Common variants in polygenic schizophrenia
por: Glessner, Joseph T, et al.
Publicado: (2009)

Changes in health-related quality of life from 6 months to 2 years after discharge from intensive care
por: Kvale, Reidar, et al.
Publicado: (2003)

Cost of intensive care in a Norwegian University hospital 1997–1999
por: Flaatten, Hans, et al.
Publicado: (2003)

Nurses’ discursive construction of older adult immigrant patients in hospitals
por: Vestgarden, Lisbeth Alnes, et al.
Publicado: (2023)

Lymphoplasmacytic variant of multiple myeloma
por: Johansen, Silje, et al.
Publicado: (2022)

Large outbreak of mumps virus genotype G among vaccinated students in Norway, 2015 to 2016
por: Veneti, Lamprini, et al.
Publicado: (2018)

The impact of global lineage dynamics, border restrictions, and emergence of the B.1.1.7 lineage on the SARS-CoV-2 epidemic in Norway
por: Osnes, Magnus N, et al.
Publicado: (2021)

Validation of a point-of-care capillary lactate measuring device (Lactate Pro 2)
por: Raa, Anette, et al.
Publicado: (2020)

The evolution of human influenza A viruses from 1999 to 2006: A complete genome study
por: Bragstad, Karoline, et al.
Publicado: (2008)

Uptake of genetic testing by the children of Lynch syndrome variant carriers across three generations
por: Seppälä, Toni T, et al.
Publicado: (2017)

Rural High North: A High Rate of Fatal Injury and Prehospital Death
por: Bakke, Håkon Kvåle, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ktqckavg5rpmq2pt6eb0ko2nge